Senate Bill 1062
115th Congress(2017-2018)
FDA Reporting Transparency and Accountability Act
Introduced
Introduced in Senate on May 4, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1062
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
FDA Reporting Transparency and Accountability Act
This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.
May 4, 2017
05/04/2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
05/04/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:36:30 PM